[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2018-002244-82"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "Phase Ib",
            "TNBC",
            "advanced",
            "metastatic",
            "immunotherapy",
            "PDR001,",
            "LAG525",
            "NIR178",
            "INC280",
            "MCS110",
            "ACZ885"
        ],
        "dcp_id": null,
        "interventional_model": "Single Group",
        "lead_org": "Novartis Pharmaceuticals Corporation",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Main Inclusion Criteria:\r\n\r\n          -  Patients with advanced/metastatic TNBC (defined as HER-2 negative with <1% of tumor\r\n             cell nuclei immunoreactive for estrogen receptor (ER) and progesterone receptor (PR)),\r\n             with measurable disease as determined by RECIST version 1.1 (refer to Appendix 16.1).\r\n             Tumor lesions previously irradiated or subjected to other loco-regional therapy will\r\n             only be considered measurable if there is documented disease progression at the\r\n             treated site prior to study entry.\r\n\r\n          -  Patients should have received standard chemotherapy for advanced or metastatic disease\r\n             but should not have received more than 2 prior lines of chemotherapy. Neoadjuvant or\r\n             adjuvant chemotherapy will count as one prior line.\r\n\r\n          -  Patients must have received prior systemic treatment that included taxane-based\r\n             chemotherapy for neoadjuvant or metastatic disease.\r\n\r\n          -  Patients must have a site of disease amenable to core needle biopsy, and be a\r\n             candidate for tumor biopsy according to the treating institution's guidelines.\r\n             Patients must be willing to undergo a new tumor biopsy at screening, and during\r\n             therapy on the study. Exceptions may be considered after documented discussion with\r\n             Novartis. Patients with available archival tumor tissue obtained \u22646 months prior to\r\n             study treatment initiation do not need to undergo a new tumor biopsy at screening, if\r\n             the patient has not received any anti-cancer therapy since the biopsy was taken, and\r\n             if adequate tissue is available.\r\n\r\n        Main exclusion criteria applicable to all treatment arms:\r\n\r\n          -  Patient has received prior treatment with anti-LAG-3, anti-PD-1, anti-PD-L1, or\r\n             anti-PD-L2 antibody (any line of therapy).\r\n\r\n          -  Presence of symptomatic central nervous system (CNS) metastases, or CNS metastases\r\n             that require local CNS-directed therapy (such as radiotherapy or surgery), or\r\n             increasing doses of corticosteroids within 2 weeks prior to initiating study\r\n             treatment.\r\n\r\n          -  History of severe hypersensitivity reactions to any ingredient of study drug(s) and\r\n             other mAbs and/or their excipients.\r\n\r\n          -  Impaired cardiac function or clinically significant cardiac disease.\r\n\r\n          -  HIV infection.\r\n\r\n          -  Patients with active hepatitis B virus (HBV) or hepatitis C virus (HCV) infection,\r\n             including those with inactive disease for patients receiving either capmatinib, MCS110\r\n             or canakinumab.\r\n\r\n          -  Active, known or suspected autoimmune disease.\r\n\r\n          -  History of or current interstitial lung disease or pneumonitis grade \u2265 2.\r\n\r\n          -  Subjects with tuberculosis (TB), for patients receiving either MCS110 or canakinumab.\r\n\r\n        Other eligibility criteria apply."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ACTUAL",
        "detail_description": null,
        "official_title": "A Phase Ib, Multicenter, Open-label Dose Escalation and Expansion Platform Study of Select Immunotherapy Combinations in Adult Patients With Triple-negative Breast Cancer",
        "_phase_sort_order": 4,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "at month 18",
                "name": "Best overall response (BOR)",
                "description": "Month 18 is assumed to be study end",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at baseline and at Day 43",
                "name": "Changes from baseline of PD markers in tumor tissue (TILs, CD8, PD-L1, LAG-3)",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Dose intensities",
                "description": "Month 18 is assumed to be study end",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Frequency of dose interuptions",
                "description": "Month 18 is assumed to be study end",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Frequency of dose reductions",
                "description": "Month 18 is assumed to be study end",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Incidence of Adverse Events (AEs) and Serious Adverse Events (SAEs) as a measure of safety",
                "description": "Month 18 is assumed to be study end",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "at Day 28",
                "name": "Incidence of dose limiting toxicities (DLTs) of treatment (Escalation only)",
                "description": "end of first cycle",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of canakinumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of capmatinib",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of LAG525",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of MCS110",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of NIR178",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (AUC) of spartalizumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of canakinumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of capmatinib",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of LAG525",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of MCS110",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of NIR178",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Cmax) of spartalizumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of canakinumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of capmatinib",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of LAG525",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of MCS110",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of NIR178",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 12",
                "name": "PK parameter (Tmax) of spartalizumab",
                "description": "cycle 12",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 29, Day 57, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Plasma concentration of NIR178, NJI675, capmatinib",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 29, Day 57, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Presence of anti-canakinumab antibodies",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 29, Day 57, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Presence of anti-LAG525 antibodies",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 29, Day 57, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Presence of anti-MCS110 antibodies",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 29, Day 57, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Presence of anti-spartalizumab antibodies",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Progression free survival (PFS) per RECIST v1.1 and iRECIST",
                "description": "Month 18 is assumed to be study end",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at Day 1, Day 8, Day 15, Day 29, Day 57, Day 65, Day 70, Day 85, Day 113, Day 141, Day 197, Day 253, Day 309 and EOT",
                "name": "Serum concentration of spartalizumab, LAG525, MCS110, canakinumab",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "at month 18",
                "name": "Severity of Adverse Events (AEs) and Serious Adverse Events (SAEs) as a measure of safety",
                "description": "Month 18 is assumed to be study end",
                "type_code": "PRIMARY"
            }
        ],
        "phase": "I",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 4,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03742349",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER-Negative PR-Negative ERBB2-Negative",
                    "ER-PR-HER2/neu-",
                    "ER-negative PR-negative HER2/neu-negative",
                    "ER/PR/HER2 Negative",
                    "ESR1/PGR/ERBB2 Negative Finding",
                    "Triple Negative Breast Cancer Finding",
                    "Triple Negative Breast Cancer Result",
                    "Triple-Negative Breast Cancer Result",
                    "triple-negative breast cancer"
                ],
                "nci_thesaurus_concept_id": "C71428",
                "name": "Triple-Negative Breast Cancer Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C35681",
                    "C21281",
                    "C20420",
                    "C3367",
                    "C36292",
                    "C16612",
                    "C38349",
                    "C28656",
                    "C94299",
                    "C21295",
                    "C20103",
                    "C165233",
                    "C25872",
                    "C20709",
                    "C17756",
                    "C54362",
                    "C20719",
                    "C77140",
                    "C25871",
                    "C25870"
                ],
                "parents": [
                    "C165233",
                    "C17756",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C54362"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Negative",
                    "ER Negative",
                    "ER-",
                    "ER-Alpha Negative",
                    "ERA Negative",
                    "ESR Negative",
                    "ESR1 Negative",
                    "ESRA Negative",
                    "ESTRR Negative",
                    "Estrogen Receptor 1 Negative",
                    "Estrogen Receptor Alpha Negative",
                    "NR3A1 Negative",
                    "Negative",
                    "Negative Estrogen Receptor",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Negative"
                ],
                "nci_thesaurus_concept_id": "C15493",
                "name": "Estrogen Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C165744",
                    "C21295",
                    "C35681",
                    "C77140",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C38349",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16150"
                ],
                "parents": [
                    "C16150",
                    "C165744",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C20719",
                    "C35681",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C16152",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C38349",
                    "C94299",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C21295",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Negative",
                    "PGR Negative",
                    "PR Negative",
                    "PR-"
                ],
                "nci_thesaurus_concept_id": "C15497",
                "name": "Progesterone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C165744",
                    "C21295",
                    "C28656",
                    "C35681",
                    "C77140",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16149"
                ],
                "parents": [
                    "C16149",
                    "C165744",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165744",
                "name": "Hormone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C35681",
                    "C77140",
                    "C3367",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C165233",
                    "C188928"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35681"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HR Status"
                ],
                "nci_thesaurus_concept_id": "C188928",
                "name": "Hormone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C36292",
                    "C94299"
                ],
                "parents": [
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2023-02-06",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage III Breast Cancer AJCC v8",
                    "Anatomic Stage III Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139541",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIA Breast Cancer AJCC v8",
                    "Anatomic Stage IIIA Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139542",
                "name": "Stage IIIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIB Breast Carcinoma AJCC v8",
                    "Anatomic Stage IIIB Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139543",
                "name": "Stage IIIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IIIC Breast Carcinoma AJCC v8",
                    "Anatomic Stage IIIC Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139544",
                "name": "Stage IIIC Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139541"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage III Breast Carcinoma AJCC v8",
                    "Prognostic Stage III Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139582",
                "name": "Stage III Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIA Breast Cancer AJCC v8",
                    "Prognostic Stage IIIA Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139583",
                "name": "Stage IIIA Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIB Breast Carcinoma AJCC v8",
                    "Prognostic Stage IIIB Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139584",
                "name": "Stage IIIB Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IIIC Breast Carcinoma AJCC v8",
                    "Prognostic Stage IIIC Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139585",
                "name": "Stage IIIC Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139582"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Prognostic Stage IV Breast Cancer AJCC v8",
                    "Prognostic Stage IV Breast Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139587",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139554"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153348",
                "name": "Metastatic Triple-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C71732",
                    "C190677"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Estrogen Receptor and Progesterone Receptor Negative Breast Carcinoma",
                    "Hormone Receptor Negative Breast Adenocarcinoma",
                    "Hormone Receptor-Negative Breast Carcinoma",
                    "ER and PR Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C165743",
                "name": "Hormone Receptor Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Breast",
                    "Tumor of Breast",
                    "Breast Tumor",
                    "Neoplasm of the Breast",
                    "Neoplasm of Breast"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26709",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma of the Breast",
                    "Cancer of Breast",
                    "Carcinoma of Breast",
                    "Breast cancer, NOS",
                    "Mammary Carcinoma",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9335",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Hormone Receptor Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C190677",
                "name": "Metastatic Hormone Receptor-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165698",
                    "C165743"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C170728",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Neoplasm of the Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C2910"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Adenocarcinoma of Breast",
                    "Mammary adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165698",
                "name": "Metastatic Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153238",
                    "C4124",
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C53553",
                "name": "Breast Carcinoma by Gene Expression Profile",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Triple-Negative Breast Carcinoma",
                    "Triple Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C71732",
                "name": "Triple-Negative Breast Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C53553",
                    "C165743"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Prognostic Stage",
                    "Breast Cancer by AJCC v8 Prognostic Stage Group"
                ],
                "nci_thesaurus_concept_id": "C139554",
                "name": "Breast Cancer by AJCC v8 Prognostic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "CADPT01A12101C",
        "active_sites_count": 1,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [],
                "name": "1: spartalizumab + LAG525 + NIR178",
                "description": "phase Ib (escalation and expansion)",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "2: spartalizumab +LAG525 +capmatinib",
                "description": "phase Ib (escalation and expansion)",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "3: spartalizumab + LAG525 + MCS110",
                "description": "phase Ib (escalation and expansion)",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "4: spartalizumab +LAG525 +canakinumab",
                "description": "phase Ib (escalation and expansion)",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C122683",
                        "name": "Ieramilimab",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C134305"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-LAG3 Monoclonal Antibody",
                            "Anti LAG-3 MoAb"
                        ],
                        "nci_thesaurus_concept_id": "C134305",
                        "name": "Anti-LAG-3 Monoclonal Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C143250",
                            "C129822",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C142374",
                        "name": "Adenosine A2A Receptor Antagonist NIR178",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2139"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Protein Antagonist",
                            "Anti-cancer Protein Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent",
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Inhibitor Agent",
                            "Enzyme Antagonist"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1-targeting Agent",
                            "Programmed Cell Death Protein 1 Inhibitor",
                            "Anti-PD-1 Agent",
                            "Protein PD-1 Inhibitor",
                            "PD-1 Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C124946",
                        "name": "PD1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C143250"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Immune Modulators",
                            "Biomodulators",
                            "BRM",
                            "Immunomodulating Agent",
                            "Immune Mediators",
                            "Immunopotentiators",
                            "Immunomodulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biological Response Modifier",
                            "Immunomodulatory Agent"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibody",
                            "Monoclonal Antibodies"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C90564",
                        "name": "Capmatinib",
                        "description": "An orally bioavailable inhibitor of the proto-oncogene c-Met (hepatocyte growth factor receptor [HGFR]) with potential antineoplastic activity. c-Met inhibitor INCB028060 selectively binds to c-Met, thereby inhibiting c-Met phosphorylation and disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met, a receptor tyrosine kinase overexpressed or mutated in many tumor cell types, plays key roles in tumor cell proliferation, survival, invasion, metastasis, and tumor angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C1742",
                            "C1967",
                            "C129825"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PTK Inhibitors",
                            "TK Inhibitors",
                            "Protein Tyrosine Kinase Inhibitors"
                        ],
                        "nci_thesaurus_concept_id": "C1967",
                        "name": "Tyrosine Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-1 Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C128037",
                        "name": "Anti-PD1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C124946",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C80044",
                        "name": "Lacnotuzumab",
                        "description": "A humanized monoclonal antibody directed against macrophage colony-stimulating factor (M-CSF) with potential anti-osteolytic activity. Anti-M-CSF monoclonal antibody MCS110 binds to M-CSF and blocks M-CSF-mediated signaling through the M-CSF receptor CD116 expressed on osteoclasts, which may result in inhibition of M-CSF-induced osteoclast differentiation and so osteoclastic bone resorption.  Osteoclasts are derived through the fusion of cells of the monocyte/macrophage lineage. Osteoblasts and stromal cells may react to bone metastases by producing M-CSF and its osteoclastogenic cofactor RANKL (receptor activator of NF-kappaB ligand). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Angiogenic Agents",
                            "Angiogenesis Antagonists",
                            "Antiangiogenic Agent",
                            "Angiogenesis Blockers",
                            "Antiangiogenesis Agents"
                        ],
                        "nci_thesaurus_concept_id": "C1742",
                        "name": "Angiogenesis Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Immunologics",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Biological Products"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C121625",
                        "name": "Spartalizumab",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C128037"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Tumor-Specific Treatment Agents",
                            "Antineoplastics",
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antineoplastic Drugs",
                            "Cancer Drug",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Anticancer Biological",
                            "Anti-cancer Biological Agent",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug Substance",
                            "Pharmacologic Agent",
                            "Pharmacological Substance",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunostimulating Agent"
                        ],
                        "nci_thesaurus_concept_id": "C2139",
                        "name": "Immunostimulant",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Ilaris"
                        ],
                        "nci_thesaurus_concept_id": "C80971",
                        "name": "Canakinumab",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C20401"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-02809",
        "why_study_stopped": "This was a sponsor decision and was not a consequence of any safety concern",
        "brief_summary": "This is a Phase Ib, open label, dose escalation study of spartalizumab + LAG525 in\r\n      combination with NIR178, capmatinib, MCS110, or canakinumab, followed by a dose expansion in\r\n      adult patients with advanced or metastatic TNBC.\r\n\r\n      During the dose-escalation part of each treatment arm, patients will be treated with fixed\r\n      doses of spartalizumab + LAG525 in combination with partner investigational drugs to be\r\n      escalated until the MTD is reached or a lower RDE is established: NIR178, capmatinib, MCS110,\r\n      or canakinumab. It is anticipated that other partner study drugs may be added in the future\r\n      by protocol amendment.\r\n\r\n      After the determination of the MTD/RDE for a particular treatment arm, dose expansion may\r\n      begin in that arm in order to further assess safety, tolerability, PK/PD, and anti-tumor\r\n      activity of each combination at the MTD/RDE. Dose expansion arms may initiate only after\r\n      consideration by the Investigators and Novartis of all available toxicity information, the\r\n      assessment of risk to future patients from the BLRM, and the available PK, preliminary\r\n      efficacy, and PD information. There is no requirement for dose-escalation treatment arms\r\n      reaching an MTD/RDE to proceed to dose expansion.",
        "brief_title": "Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).",
        "status_history": [
            {
                "status_date": "2023-02-06T00:00:00.000002",
                "status": "ADMINISTRATIVELY_COMPLETE"
            },
            {
                "status_date": "2022-01-26T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2019-01-31T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 220,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 8,
        "start_date": "2019-01-31",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Administratively Complete",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Breast"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-02-06",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]